Expanded Neonatal Screening in the Netherlands

Four tandem mass-spectrometry-based systems, reagents, and software will support Netherlands' five hospital screening centers. The program will include comprehensive training, customer support, and service to ensure total quality at every stage of the screening process. The five centers will expand nationwide screening from three to 14 disorders.

PerkinElmer, Inc. (Wellesley, MA, USA), a global technology company, was selected for the expanded neonatal screening program. The Specimen Gate Data Suite laboratory-information-management system from PerkinElmer will allow the country's screening centers to implement a solution that will electronically track laboratory workflow from sample receipt and preparation through analysis, quality control review, reporting, and follow up, to advance the pace and precision of the screening program.

"We are honored that the Netherlands has selected PerkinElmer technology to aid in this expanded national initiative to identify congenital disorders early,” said Gregory L. Summe, chairman and CEO of PerkinElmer. "This agreement further fortifies PerkinElmer's leadership position in supplying neonatal screening technology and support to countries around the world.”

PerkinElmer has more than 10 years of experience with expanding newborn screening programs using tandem mass spectrometry and more than 20 years of experience in the field of newborn screening. The company recently announced that its technology was selected to expand newborn screening programs in Russia and Israel.



Related Links:
PerkinElmer